NAD+-boosting compounds enhance nitric oxide production and prevent oxidative stress in endothelial cells exposed to plasma from patients with COVID-19
Journal Article
Overview
publication date
- November 1, 2023
has subject area
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Coenzymes - NAD
- Coronavirus Infections - COVID-19
- Endothelial Cells
- Female
- Humans
- Infections - COVID-19
- Infections - COVID-19
- Inorganic Chemicals - Nitric Oxide
- Inorganic Chemicals - Reactive Oxygen Species
- Lung Diseases - COVID-19
- Male
- Metabolism - Oxidative Stress
- Middle Aged
- Nicotinamide Mononucleotide
- Nitrogen Compounds - Nitric Oxide
- Nitrogen Compounds - Nitric Oxide
- Nucleic Acids, Nucleotides, and Nucleosides - NAD
- Oxygen Compounds - Nitric Oxide
- Oxygen Compounds - Reactive Oxygen Species
- Purines - NAD
- Respiratory Tract Diseases - COVID-19
- Respiratory Tract Diseases - COVID-19
- Ribonucleotides - NAD
- SARS-CoV-2
- Stress, Physiological - Oxidative Stress
- Virus Diseases - COVID-19
- Young Adult
has restriction
- closed
Date in CU Experts
- October 11, 2023 1:33 AM
Full Author List
- Freeberg KA; Ludwig KR; Chonchol M; Seals DR; Rossman MJ
author count
- 5
citation count
- 0
published in
Other Profiles
International Standard Serial Number (ISSN)
- 1089-8603
Electronic International Standard Serial Number (EISSN)
- 1089-8611
Digital Object Identifier (DOI)
Additional Document Info
start page
- 1
end page
- 7
volume
- 140